Morbidity

Percent prevalence of chronic conditions among users of chronic drugs program, 2016*

Chronic conditions	Prevalence
Cardiovascular diseases, atherosclerosis, coagulation problems and hypertension	47%
Diabetes	15%
Ulcers	10%
High cholesterol level	10%
Other diseases (Rheumatism, uric acid, glaucoma, osteoporosis...)	8%
Diseases of the nervous system	3%
Epilepsy	3%
Thyroid Problems	2%
Asthma	2%

*For previous years check the Statistical Bulletins' page

Newly reported HIV cases, 2020

Newly reported HIV cases,2021

Newly reported HIV cases, 2022

New reported HIV cases,2023

New reported HIV cases,2024

https://www.moph.gov.lb/userfiles/files/Prevention/TB%20Program/NTP-NAP%20Annual%20Report-2024.pdf

Number of Measles cases

	2012	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023
Measles	9	1,760	235	39	44	126	952	1070	-	28	95	351

Source :MoPH 01/09/2024

Number of Tuberculosis cases*

Tuberculosis cases	2012	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024
Total number of cases	630	689	682	666	657	632	668	760	656	466	510	510	540
Number of Lebanese cases	330	341	337	312	305	271	254	288	277	233	263	249	225
Number of Non-Lebanese cases	300	348	345	354	352	361	414	472	379	233	247	261	315

*MOPH National Tuberculosis Program 01/05/2025

The trend in Tuberculosis cases by Nationality between 2019 and 2024

...

All

ATC	Name	B/G	Ingredients	Dosage	Form	Price
L04AX03	EBETREXAT	G	Methotrexate - 15mg/1.5ml	15mg/1.5ml	Injectable solution	2,135,366 L.L
C01CA26	EPHEDRINE AGUETTANT	G	Ephedrine HCl - 30mg/ml	30mg/ml	Injectable solution	614,136 L.L
C01CA26	EPHEDRINE RENAUDIN	G	Ephedrine HCl - 30mg/ml	3%	Injectable solution	693,423 L.L
C01CA26	EPHEDRINE AGUETTANT	G	Ephedrine HCl - 3mg/ml	3mg/ml	Injectable solution	7,827,491 L.L
V03AF03	EUROFOLIC	G	Folic acid as Calcium Folinate Hydrate - 100mg/10ml	10mg/ml	Injectable solution	L.L
S01LA05	EYLEA	BioTech	Aflibercept - 40mg/ml	40mg/ml	Injectable solution	65,161,855 L.L
S01LA05	EYLEA	BioTech	Aflibercept - 8mg/0.07ml	8mg/0.07ml	Injectable solution	78,332,387 L.L
B05BB02	ELECTROLYE 67	G	Calcium gluconate - 0.10g/100ml, Potassium chloride - 0.075g/100ml, Sodium chloride - 0.30g/100ml, Dextrose, H2O - 5.0g/100ml		Injectable solution	165,727 L.L
L01DB03	EPIRUBICINE VIATRIS 2MG/ML	G	Epirubicin HCl - 10mg/5ml	10mg/5ml	Injectable solution	855,212 L.L
L01DB03	EPIRUBICINE VIATRIS 2MG/ML	G	Epirubicin HCl - 50mg/25ml	50mg/25ml	Injectable solution	3,914,242 L.L
G03GA09	ELONVA	BioHuman	Corifollitropin alfa - 100mcg/0.5ml	100mcg/0.5ml	Injectable solution	35,131,802 L.L
G03GA09	ELONVA	BioTech	Corifollitropin alfa - 150mcg/0.5ml	150mcg/0.5ml	Injectable solution	44,141,610 L.L
B02BD02	ESPEROCT	BioTech	Turoctocog Alfa pegol (recombinant coagulation factor VIII) - 500IU/Vial	500IU/Vial	Injectable powder for solution+diluent	38,126,657 L.L
B02BD02	ESPEROCT	BioTech	Turoctocog Alfa pegol (recombinant coagulation factor VIII) - 1000IU/Vial	1000IU/Vial	Injectable powder for solution+diluent	75,761,046 L.L
L01AA01	ENDOXAN	B	Cyclophosphamide (monohydrate) - 500mg	500mg	Injectable powder for solution	764,646 L.L
A02BC05	ESAC	G	Esomeprazole sodium - 40mg	40mg	Injectable powder for solution	430,030 L.L
A02BC05	ESOMEPRAZOLE NORMON	G	Esomeprazole - 40mg	40mg	Injectable powder for solution	430,030 L.L
A02BC05	ESSIUM	G	Esomeprazole - 40mg	40mg	Injectable powder for solution	314,459 L.L
L01AA01	ENDOXAN	B	Cyclophosphamide (monohydrate) - 500mg	500mg	Injectable powder for solution	L.L
L04AA33	ENTYVIO	BioTech	Vedolizumab - 300mg	300mg	Injectable powder for concentrate for solution	152,492,033 L.L
L01FD04	ENHERTU	BioTech	Trastuzumab deruxtecan - 100mg	100mg	Injectable powder for concentrate for solution	178,517,964 L.L
J01DH03	ERTANZ	G	Ertapenem - 1g	1g	Injectable powder	2,521,049 L.L
A02BC01	ESELAN	G	Omeprazole (sodium) - 40mg	40mg	Injectable lyophilised powder for solution	2,073,549 L.L
L01XX02	ERWINASE	BioTech	Erwinia L-asparaginase - 10,000IU	10,000IU	Injectable lyophilised powder for solution	444,434,845 L.L
L01CA04	EBERELBIN	G	Vinorelbine (tartrate) - 50mg/5ml	50mg/5ml	Injectable concentrated solution	6,834,783 L.L
L01CB01	ETOPOSIDE EBEWE	G	Etoposide - 100mg/5ml	100mg/5ml	Injectable concentrated solution	768,678 L.L
L01CB01	ETOPOSIDE VIATRIS 20MG/ML	G	Etoposide - 100mg/5ml	100mg/5ml	Injectable concentrated solution	1,544,466 L.L
L01CD01	EBETAXEL	G	Paclitaxel - 30mg/5ml	30mg/5ml	Injectable concentrated solution	2,983,330 L.L
L01CD01	EBETAXEL	G	Paclitaxel - 150mg/25ml	150mg/25ml	Injectable concentrated solution	15,457,059 L.L
L01CB01	ETOPOSIDE VIATRIS 20MG/ML	G	Etoposide - 100mg/5ml	100mg/5ml	Injectable concentrated solution	L.L

...